Table 2.
Gene name | Primer sequence | Product (bp) |
---|---|---|
β‐actin | F: 5′‐CGCCAACCGCGAGAAGAT‐3′ | 168 |
R: 5′‐CGTCACCGGAGTCCATCA‐3′ | ||
ALP | F: 5′‐TGGAGCTTCAGAAGCTCAACACCA‐3′ | 454 |
R: 5′‐ATCTCGTTGTCTGAGTACCAGTCC‐3′ | ||
cbfa1 | F: 5′‐CTCACTACCACACCTACCTG‐3′ | 320 |
R: 5′‐TCAATATGGTCGCCAAACAGATTC‐3′ | ||
OPN | F: 5′‐CATCTCAGAAGCAGAATCTCC‐3′ | 313 |
R: 5′‐CCATAAACCACACTATCACCTC‐3′ | ||
PTH‐R1 | F: 5′‐CACAGCCTCATCTTCATGG‐3′ | 357 |
R: 5′‐GCATCTCATAGTGCATCTGG‐3′ | ||
C/EBPα | F: 5′‐GTCGGTGGACAAGAACAGC‐3′ | 234 |
R: 5′‐ATGGCCTTGACCAAGGAGC‐3′ | ||
PPARγ2 | F: 5′‐GCTGTTATGGGTGAAACTCTG‐3′ | 351 |
R: 5′‐ATAAGGTGGAGATGCAGGCTC‐3′ |
ALP, alkaline phosphatase; C/EBPα, CAAT/enhancer‐binding protein α; cbfa1, core binding factor alpha 1; F, forward; OPN, osteopontin; PPARγ2, proliferator‐activated receptor γ2; PTH‐R1, parathyroid hormone receptor type 1; R, reverse.